Alzex Neuropharma Inc.
TRRI
$0.00
-$0.07-99.58%
OTC PK
| 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | |
|---|---|---|---|---|---|
| Net Income | 95.60K | 117.80K | 79.80K | -- | -- |
| Total Depreciation and Amortization | 93.30K | 95.00K | 70.70K | -- | -- |
| Total Amortization of Deferred Charges | -27.10K | -27.10K | -100.00 | -- | -- |
| Total Other Non-Cash Items | 61.10K | 4.50K | 0.00 | -- | -- |
| Change in Net Operating Assets | 107.50K | -200.70K | -78.50K | -- | -- |
| Cash from Operations | 330.70K | -10.30K | 72.00K | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 33.40K | 138.70K | 93.20K | -- | -- |
| Total Debt Repaid | -211.20K | -73.10K | -71.40K | -- | -- |
| Issuance of Common Stock | 82.50K | 82.50K | 82.50K | -- | -- |
| Repurchase of Common Stock | -82.50K | -82.50K | -82.50K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -44.10K | -44.10K | -44.10K | -- | -- |
| Cash from Financing | -221.90K | 21.50K | -22.20K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 108.80K | 11.20K | 49.80K | -- | -- |